Mirum Pharmaceuticals (MIRM) News Today $43.69 +0.27 (+0.62%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$43.68 -0.02 (-0.03%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period First Trust Advisors LP Cuts Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)First Trust Advisors LP lessened its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 8.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 134,181 shares of the company's stock after selling 12,230 shares during thMay 3 at 4:02 AM | marketbeat.comAdage Capital Partners GP L.L.C. Has $6.20 Million Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Adage Capital Partners GP L.L.C. increased its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 87.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 150,000 shares of the company's stock after purchasing an aMay 1 at 5:30 AM | marketbeat.comPrice T Rowe Associates Inc. MD Has $58.83 Million Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Price T Rowe Associates Inc. MD boosted its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 10.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,422,729 shares of the company'sMay 1 at 5:11 AM | marketbeat.comDark Forest Capital Management LP Invests $308,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Dark Forest Capital Management LP acquired a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 7,460 shares of the company's stock, valued at approximaMay 1 at 5:02 AM | marketbeat.comOxford Asset Management LLP Buys New Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Oxford Asset Management LLP acquired a new position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 6,587 shares of the company's stock, valuedApril 30, 2025 | marketbeat.comLord Abbett & CO. LLC Acquires 40,986 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Lord Abbett & CO. LLC lifted its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 5.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 782,354 shares of the company's stock after purApril 29, 2025 | marketbeat.comSyon Capital LLC Invests $276,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Syon Capital LLC acquired a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,682 shares of the company's stock, valued at appApril 28, 2025 | marketbeat.comPenn Capital Management Company LLC Lowers Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Penn Capital Management Company LLC lessened its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 10.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 278,427 shares of the company's stock after selling 30,817 sharesApril 26, 2025 | marketbeat.comCanada Pension Plan Investment Board Invests $1.73 Million in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Canada Pension Plan Investment Board acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 41,800 shApril 26, 2025 | marketbeat.comMarshall Wace LLP Buys 152,191 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Marshall Wace LLP raised its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 641.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 175,913 shares of the company's stock after acquApril 25, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Rating of "Buy" from BrokeragesApril 24, 2025 | americanbankingnews.comRock Springs Capital Management LP Sells 108,924 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Rock Springs Capital Management LP cut its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,471,564 shares of the company's stock after selling 108,924 shApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Grows Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Renaissance Technologies LLC lifted its holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 67.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 101,248 shares of the company's stock after purchasing an adApril 23, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Purchased by Invesco Ltd.Invesco Ltd. boosted its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 299,279 shares of the company's stock after purchasing an additional 14,747 shares during theApril 23, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Position Reduced by Jump Financial LLCJump Financial LLC reduced its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 19.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,634 shares of the companApril 22, 2025 | marketbeat.comNan Fung Group Holdings Ltd Buys 19,230 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Nan Fung Group Holdings Ltd lifted its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 18.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 125,330 shares of the company's stock after buying an adApril 21, 2025 | marketbeat.comAlpha DNA Investment Management LLC Purchases Shares of 10,663 Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Alpha DNA Investment Management LLC acquired a new position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 10,663 shaApril 21, 2025 | marketbeat.comXTX Topco Ltd Invests $615,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)XTX Topco Ltd acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 14,861 shares of the company's stock, valued at apprApril 21, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from BrokeragesShares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) have earned an average recommendation of "Buy" from the eleven brokerages that are currently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy recommendation and one has assApril 21, 2025 | marketbeat.comQ1 EPS Estimate for Mirum Pharmaceuticals Lowered by AnalystMirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Mirum Pharmaceuticals in a note issued to investors on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now forecasts that thApril 20, 2025 | marketbeat.comEAM Investors LLC Cuts Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)EAM Investors LLC cut its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 23.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 72,956 shares of the company's stock after selling 22,465 sharApril 19, 2025 | marketbeat.com27,322 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Purchased by Capital Fund Management S.A.Capital Fund Management S.A. bought a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 27,322 shares of the company's stock, valued at approximatelyApril 18, 2025 | marketbeat.comGeode Capital Management LLC Grows Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Geode Capital Management LLC grew its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 0.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 943,344 shares of the coApril 17, 2025 | marketbeat.comMirum Pharmaceuticals receives FDA approval for Livmarli tablet formulationApril 15, 2025 | markets.businessinsider.comFDA Approves Mirum Pharmaceuticals’ Drug For Rare Liver Disease Patients In Tablet Form: Retail Stays BullishApril 14, 2025 | msn.comMirum’s LIVMARLI Now FDA Approved in Tablet FormulationApril 14, 2025 | finance.yahoo.comExodusPoint Capital Management LP Purchases Shares of 22,153 Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)ExodusPoint Capital Management LP purchased a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 22,153 shares of the company's stock, valued at approximately $916April 13, 2025 | marketbeat.comVanguard Group Inc. Has $100.26 Million Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Vanguard Group Inc. cut its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,424,734 shares of the company's stock after selling 71,378 shares duriApril 12, 2025 | marketbeat.comMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 10, 2025 | businesswire.comKLP Kapitalforvaltning AS Makes New $277,000 Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)KLP Kapitalforvaltning AS bought a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 6,700 shares of the company's stock, valued at approximately $277,000. A number of othApril 8, 2025 | marketbeat.comRhenman & Partners Asset Management AB Lowers Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Rhenman & Partners Asset Management AB reduced its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 29.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7April 7, 2025 | marketbeat.comJ.P. Morgan Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)April 5, 2025 | markets.businessinsider.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Bought by Clearbridge Investments LLCClearbridge Investments LLC increased its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 907,317 shares of the company's stock after purchasing anApril 3, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Pictet Asset Management Holding SAPictet Asset Management Holding SA decreased its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 860,096 shares of the company's stock after sellinApril 1, 2025 | marketbeat.comNEOS Investment Management LLC Sells 26,990 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)NEOS Investment Management LLC decreased its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 60.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 17,693 shares of the company's stock after selling 26,990 shares during tApril 1, 2025 | marketbeat.comLoomis Sayles & Co. L P Acquires 78,708 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Loomis Sayles & Co. L P raised its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 15.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 578,024 shares of the companMarch 30, 2025 | marketbeat.com10,000 Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Purchased by Congress Wealth Management LLC DECongress Wealth Management LLC DE bought a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,000 shares of the company'sMarch 30, 2025 | marketbeat.comMirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?March 28, 2025 | msn.comMirum Pharmaceuticals partner Takeda receives approval for Livmarli in JapanMarch 28, 2025 | markets.businessinsider.comLIVMARLI Now Approved in Japan for ALGS and PFICMarch 27, 2025 | finance.yahoo.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Rating of "Buy" from AnalystsMirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) has been given a consensus rating of "Buy" by the eleven brokerages that are covering the company, Marketbeat Ratings reports. Ten equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buMarch 25, 2025 | marketbeat.comMirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell CallMarch 24, 2025 | seekingalpha.comMaintaining An 'Accumulate' Rating On Mirum Pharmaceuticals, Lots To LikeMarch 24, 2025 | seekingalpha.comRaymond James Financial Inc. Purchases New Shares in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Raymond James Financial Inc. acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 256,612 shares of the company's stock, vMarch 21, 2025 | marketbeat.comInsider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Sells 7,879 Shares of StockMirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) COO Peter Radovich sold 7,879 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $44.21, for a total transaction of $348,330.59. Following the completion of the sale, the chief operating officer now owns 18,672 shares in the company, valued at approximately $825,489.12. This trade represents a 29.67 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.March 19, 2025 | marketbeat.comChristopher Peetz Sells 27,279 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) StockMirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) CEO Christopher Peetz sold 27,279 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $44.21, for a total transaction of $1,206,004.59. Following the transaction, the chief executive officer now directly owns 138,641 shares of the company's stock, valued at approximately $6,129,318.61. This trade represents a 16.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.March 19, 2025 | marketbeat.comMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells $2,554,826.10 in StockMirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) SVP Jolanda Howe sold 57,606 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $44.35, for a total value of $2,554,826.10. Following the completion of the transaction, the senior vice president now owns 4,841 shares of the company's stock, valued at $214,698.35. The trade was a 92.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.March 19, 2025 | marketbeat.comInsider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Sells 7,879 Shares of StockMarch 19, 2025 | insidertrades.comMirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Up - Here's WhyMirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Up - Should You Buy?March 18, 2025 | marketbeat.comBank of New York Mellon Corp Has $5.14 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)Bank of New York Mellon Corp increased its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 8.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,328 shares of the company's stock aMarch 18, 2025 | marketbeat.com Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRM Media Mentions By Week MIRM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRM News Sentiment▼1.530.73▲Average Medical News Sentiment MIRM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRM Articles This Week▼75▲MIRM Articles Average Week Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Today Revolution Medicines News Today Lantheus News Today BridgeBio Pharma News Today TG Therapeutics News Today Legend Biotech News Today Sarepta Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today ADMA Biologics News Today Blueprint Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRM) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MIRM Stock Free MIRM Stock Alerts